Latest Breaking News On - Patients with ros1 positive metastatic non small cell lung cancer - Page 1 : vimarsana.com

Vamsidhar Velcheti, MD, discusses the significance of the FDA approval of the ROS1 TKI repotrectinib in patients with ROS1-positive metastatic non–small cell lung cancer.

Vamsidhar velchetiDepartment of medicineYork universityLangone perlmutter cancer centerGrossman school of medicineNew york universityGrossman schoolPerlmutter cancer centerNew york university grossman school of medicineNyu langone perlmutter cancer centerFda approval of repotrectinibPatients with ros1 positive metastatic non small cell lung cancer